ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VENN Venn Life Sciences Holdings Plc

6.85
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Venn Life Sciences Holdings Plc LSE:VENN London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.85 6.70 7.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Venn Life Sciences Share Discussion Threads

Showing 1526 to 1538 of 1825 messages
Chat Pages: 73  72  71  70  69  68  67  66  65  64  63  62  Older
DateSubjectAuthorDiscuss
11/12/2018
10:14
Yump. Couldn't agree more. These idiots will hold and hold until such time they often lose everything. Investors can claw through my posts to see where I have made and where I have given advice to stay clear. Obviously we all have losers but generally I for one do pretty well all considered. It is also worth mentioning that all to often one is ridiculed for changing ones stance on a share as well. Why I do not know, as a profit is exactly that.
cocker
11/12/2018
09:55
I really thought this might do 50-100% today.

Obviously there's still a very stale distressed sellers who have got out at any price.

Considering the drop from 15-20p to 2p I thought and still do think this was a big step in the right direction.

When the mm's run low of stock I bet it has a great run at some point this month so will just hold as normal

dave4545
11/12/2018
09:50
Perhaps buywell3 would like to give everyone a list of tips for shares that will rise, rather than going around picking on shares that are clearly struggling, which have falling share prices and then saying 'I told you so'. On the balance of probabilities that will be right.

OR How about picking a share that is doing well and picking holes in that ?

There are a few posters who do that, get ridiculed by the supporters' clubs and are then proved right.

The kudos belongs entirely to them. Particularly if they've actually picked out the problems that cause the share to run into trouble.

yump
11/12/2018
08:21
Good news

Bombed out price.

This could do well from this all time low level so bought some

dave4545
11/12/2018
08:01
Venn sniff's out a opportunity within in its market that looks all set to be a good fit & earnings enhancement. At the same time raising yet more funds for a whopping 10% interest. Well as its the season for believing, shall we all just do it.
cocker
22/11/2018
09:30
It's a shame Dave has filtered me as it would be lovely to ask how many grand he is down on his recent 3 million skin shares he so called bought, especially after their latest placing today.
cocker
20/11/2018
22:22
Lol deramps it now and boasts about selling at prices from years ago and has the nerve to go at others.
dave4545
16/11/2018
17:35
Wish I'd sold at that level too :(. Virtually lost the lot now with these clowns!
jpuff
16/11/2018
10:14
whats on the menu - dead cat?
elpirata
16/11/2018
09:05
Anyone know when the next bash as the Black Rat Bar is ? the drinks/spread 2nd to none
mr hangman
15/11/2018
19:11
Any bombed out share can react to a bit of positive news. The fact that when the IPO went ahead @5p, I was one of a few who told punters to avoid, so from 5p to 0.5 is pretty good advice.Even here the share price could rise sharply, but history tells me it would be short lived.However, happy to take you up on my English lesson?
cocker
15/11/2018
16:12
Following a significant delay we are pleased to communicate that we have now received confirmation that we are to secure full service contract work valued at EUR3.4m for our Clinical Research Services (CRS) group. This new business comes from an existing client operating in the orphan disease area and the awarding of this work is testament to the quality of of the CRS group's performance on previous development programs. Activities are scheduled to commence in November and are estimated to run for circa eighteen months with relatively even billing over the project lifetime. This particular client is committed to multiple development programs and we believe we are well positioned to secure additional programs of a similar scale in the coming months.
tomboyb
15/11/2018
16:08
Always hope after Skin having turned corner today
dave4545
Chat Pages: 73  72  71  70  69  68  67  66  65  64  63  62  Older

Your Recent History

Delayed Upgrade Clock